FDA approves Sonocur, workstation
Siemens' answer to pain management, a low-energy extracorporeal shock-wave therapy system called Sonocur Basic, passed FDA muster in July. The agency approved the company's new product for use in the treatment of patients with lateral epicondylitis, a
Siemens' answer to pain management, a low-energy extracorporeal shock-wave therapy system called Sonocur Basic, passed FDA muster in July. The agency approved the company's new product for use in the treatment of patients with lateral epicondylitis, a condition commonly referred to as tennis elbow. The approval is the latest evolutionary step for shock-wave therapy, which began as a treatment for kidney stones. Its failure to effectively treat biliary stones more than a decade ago caused the technology to slip from the limelight. Pain treatment promises to rejuvenate the technology, whose latest configuration is a far cry from the bulky stone-blasting machines. Sonocur Basic features an articulating head, which is placed on the painful area. The device administers a preset number of shock waves at low energy.
Also last month, the agency cleared the multimodality workstation Avia, which is being packaged with Hitachi's new PET scanner, Sceptre. The workstation with Fusion7D is designed to process and display DICOM data from any digital imaging modality.
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
March 13th 2025Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.
